Invention Grant
- Patent Title: KLK-13 antibody inhibitor for treating dry eye
- Patent Title (中): 用于治疗干眼症的KLK-13抗体抑制剂
-
Application No.: US13129436Application Date: 2009-11-23
-
Publication No.: US08211434B2Publication Date: 2012-07-03
- Inventor: Michael E. Stern , Karyn F. Siemasko , Christopher Schaumburg , Jianping Gao
- Applicant: Michael E. Stern , Karyn F. Siemasko , Christopher Schaumburg , Jianping Gao
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agency: Allergan, Inc.
- Agent Joel B. German; Debra D. Condino
- International Application: PCT/US2009/065561 WO 20091123
- International Announcement: WO2010/062857 WO 20100603
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/40
Abstract:
Disclosed herein is a method of treating dry eye with a KLK-13 antibody.
Public/Granted literature
- US20110223170A1 KLK-13 ANTIBODY INHIBITOR FOR TREATING DRY EYE Public/Granted day:2011-09-15
Information query
